Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Staging accuracy of MR for pancreatic neuroendocrine tumor and imaging findings according to the tumor grade.

Kim JH, Eun HW, Kim YJ, Han JK, Choi BI.

Abdom Imaging. 2013 Oct;38(5):1106-14. doi: 10.1007/s00261-013-0011-y.

PMID:
23728305
2.

Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging.

Lotfalizadeh E, Ronot M, Wagner M, Cros J, Couvelard A, Vullierme MP, Allaham W, Hentic O, Ruzniewski P, Vilgrain V.

Eur Radiol. 2017 Apr;27(4):1748-1759. doi: 10.1007/s00330-016-4539-4. Epub 2016 Aug 19.

PMID:
27543074
3.

Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage.

De Robertis R, Cingarlini S, Tinazzi Martini P, Ortolani S, Butturini G, Landoni L, Regi P, Girelli R, Capelli P, Gobbo S, Tortora G, Scarpa A, Pederzoli P, D'Onofrio M.

World J Gastroenterol. 2017 Jan 14;23(2):275-285. doi: 10.3748/wjg.v23.i2.275.

4.

Evaluation of ADC measurements among solid pancreatic masses by respiratory-triggered diffusion-weighted MR imaging with inversion-recovery fat-suppression technique at 3.0T.

Yao XZ, Yun H, Zeng MS, Wang H, Sun F, Rao SX, Ji Y.

Magn Reson Imaging. 2013 May;31(4):524-8. doi: 10.1016/j.mri.2012.09.006. Epub 2012 Nov 29.

PMID:
23200681
5.

Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?

Toshima F, Inoue D, Komori T, Yoshida K, Yoneda N, Minami T, Matsui O, Ikeda H, Gabata T.

Jpn J Radiol. 2017 May;35(5):242-253. doi: 10.1007/s11604-017-0627-x. Epub 2017 Mar 3.

PMID:
28258323
6.

Intravoxel incoherent motion diffusion-weighted imaging of pancreatic neuroendocrine tumors: prediction of the histologic grade using pure diffusion coefficient and tumor size.

Hwang EJ, Lee JM, Yoon JH, Kim JH, Han JK, Choi BI, Lee KB, Jang JY, Kim SW, Nickel MD, Kiefer B.

Invest Radiol. 2014 Jun;49(6):396-402. doi: 10.1097/RLI.0000000000000028.

PMID:
24500090
7.

Pancreatic neuroendocrine tumors: correlation between histogram analysis of apparent diffusion coefficient maps and tumor grade.

Pereira JA, Rosado E, Bali M, Metens T, Chao SL.

Abdom Imaging. 2015 Oct;40(8):3122-8. doi: 10.1007/s00261-015-0524-7.

PMID:
26280127
8.

Evaluation of radiological prognostic factors of hepatic metastases in patients with non-functional pancreatic neuroendocrine tumors.

Denecke T, Baur AD, Ihm C, Steffen IG, Tischer E, Arsenic R, Pascher A, Wiedenmann B, Pavel M.

Eur J Radiol. 2013 Oct;82(10):e550-5. doi: 10.1016/j.ejrad.2013.06.017. Epub 2013 Jul 24.

PMID:
23891296
9.

Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior.

Morin E, Cheng S, Mete O, Serra S, Araujo PB, Temple S, Cleary S, Gallinger S, Greig PD, McGilvray I, Wei A, Asa SL, Ezzat S.

Cancer Med. 2013 Oct;2(5):701-11. doi: 10.1002/cam4.96. Epub 2013 Aug 6.

10.

Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.

Hyodo R, Suzuki K, Ogawa H, Komada T, Naganawa S.

Eur J Radiol. 2015 Nov;84(11):2103-9. doi: 10.1016/j.ejrad.2015.08.014. Epub 2015 Aug 22.

PMID:
26321494
11.

The value of gadoxetic acid-enhanced and diffusion-weighted MRI for prediction of grading of pancreatic neuroendocrine tumors.

Jang KM, Kim SH, Lee SJ, Choi D.

Acta Radiol. 2014 Mar;55(2):140-8. doi: 10.1177/0284185113494982. Epub 2013 Jul 29.

PMID:
23897307
12.

Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.

Server A, Kulle B, Gadmar ØB, Josefsen R, Kumar T, Nakstad PH.

Eur J Radiol. 2011 Nov;80(2):462-70. doi: 10.1016/j.ejrad.2010.07.017. Epub 2010 Aug 13.

PMID:
20708868
13.

Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma.

Kim JH, Eun HW, Kim YJ, Lee JM, Han JK, Choi BI.

Eur Radiol. 2016 May;26(5):1338-47. doi: 10.1007/s00330-015-3941-7. Epub 2015 Aug 8.

PMID:
26253257
14.

Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade.

Takeuchi M, Sasaki S, Ito M, Okada S, Takahashi S, Kawai T, Suzuki K, Oshima H, Hara M, Shibamoto Y.

Radiology. 2009 Apr;251(1):112-21. doi: 10.1148/radiol.2511080873.

PMID:
19332849
15.

Pancreatic neuroendocrine tumour: Correlation of apparent diffusion coefficient or WHO classification with recurrence-free survival.

Kim M, Kang TW, Kim YK, Kim SH, Kwon W, Ha SY, Ji SA.

Eur J Radiol. 2016 Mar;85(3):680-7. doi: 10.1016/j.ejrad.2015.12.029. Epub 2016 Jan 4.

PMID:
26826888
16.

Correlation of computed tomography imaging features and pathological features of 41 patients with pancreatic neuroendocrine tumors.

Utsumi M, Umeda Y, Takagi K, Takashi K, Nobuoka D, Yoshida R, Shinoura S, Sadamori H, Yagi T, Fujiwara T.

Hepatogastroenterology. 2015 Mar-Apr;62(138):441-6.

PMID:
25916078
17.

Intravoxel incoherent motion diffusion-weighted MR imaging for characterization of focal pancreatic lesions.

Kang KM, Lee JM, Yoon JH, Kiefer B, Han JK, Choi BI.

Radiology. 2014 Feb;270(2):444-53. doi: 10.1148/radiol.13122712. Epub 2013 Oct 28.

PMID:
24126370
18.

Preoperative grading of presumptive low-grade astrocytomas on MR imaging: diagnostic value of minimum apparent diffusion coefficient.

Lee EJ, Lee SK, Agid R, Bae JM, Keller A, Terbrugge K.

AJNR Am J Neuroradiol. 2008 Nov;29(10):1872-7. doi: 10.3174/ajnr.A1254. Epub 2008 Aug 21.

19.

Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades.

Belousova E, Karmazanovsky G, Kriger A, Kalinin D, Mannelli L, Glotov A, Karelskaya N, Paklina O, Kaldarov A.

Clin Radiol. 2017 Feb;72(2):150-158. doi: 10.1016/j.crad.2016.10.021. Epub 2016 Nov 24.

PMID:
27890421
20.

Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.

Takumi K, Fukukura Y, Higashi M, Ideue J, Umanodan T, Hakamada H, Kanetsuki I, Yoshiura T.

Eur J Radiol. 2015 Aug;84(8):1436-1443. doi: 10.1016/j.ejrad.2015.05.005. Epub 2015 May 14.

PMID:
26022520

Supplemental Content

Support Center